Prognostic value of an immunohistochemical signature in patients with pulmonary squamous cell carcinoma undergoing complete surgical resection
Open Access
- 1 February 2022
- journal article
- research article
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 14 (2) , 536-545
Abstract
Background: The Tumor Node Metastasis (TNM) stage cannot accurately predict the prognosis of patients in pulmonary squamous cell carcinoma (SQCC). The aim of the present study was to evaluate the prognostic value of immunohistochemical (IHC)-based classifiers in patients with pulmonary SQCC who underwent complete surgery resection. Methods: From January 2010 to December 2014, a total of 556 patients with SQCC who underwent complete radical resection were included. The patients were grouped into a discovery group (n=334) and a validation group (n=222). Using the least absolute shrinkage and selection operator (LASSO) regression model, we extracted IHCs that were associated with progression-free survival (PFS) and then built classifiers. Clinicopathological variables and the IHC-based classifiers were analyzed using univariable and multivariable logistic regression analyses. A nomogram to predict PFS was constructed and validated using bootstrap resampling. Results: Following the LASSO regression model, 4 IHC markers associated with PFS were identified. We used the IHC-based classifiers to stratify patients in both groups into high- and low-risk groups. PFS was better in the low-risk group than in the high-risk group in both the discovery and validation groups. Multivariate analysis demonstrated that the IHC-based classifiers were independently prognostic in predicting the PFS of patients with SQCC. The performance of the nomogram was evaluated and proven to be clinically useful. Conclusions: By combining IHC-based classification and clinicopathology, we were able to have better insight into the prognostic assessment of patients with SQCC after surgery, which can inform postoperative patient management.Keywords
This publication has 32 references indexed in Scilit:
- Lung Cancer Biomarkers: Present Status and Future DevelopmentsArchives of Pathology & Laboratory Medicine, 2013
- The Emerging Role of SOX2 in Cell Proliferation and Survival and Its Crosstalk with Oncogenic Signaling in Lung CancerStem Cells, 2013
- Three-Gene Immunohistochemical Panel Adds to Clinical Staging Algorithms to Predict Prognosis for Patients With Esophageal AdenocarcinomaJournal of Clinical Oncology, 2013
- Tumor Recurrence After Complete Resection for Non-Small Cell Lung CancerThe Annals of Thoracic Surgery, 2012
- p40 (ΔNp63) is superior to p63 for the diagnosis of pulmonary squamous cell carcinomaLaboratory Investigation, 2011
- SOX2 Silencing in Glioblastoma Tumor-Initiating Cells Causes Stop of Proliferation and Loss of TumorigenicityStem Cells, 2009
- The International Epidemiology of Lung Cancer: Geographical Distribution and Secular TrendsJournal of Thoracic Oncology, 2008
- The IASLC Lung Cancer Staging Project: Proposals for the Revision of the TNM Stage Groupings in the Forthcoming (Seventh) Edition of the TNM Classification of Malignant TumoursJournal of Thoracic Oncology, 2007
- Preoperative Evaluation of Patients Undergoing Lung Resection SurgeryaChest, 2003
- The Role of Cyclin-dependent Kinase Inhibitor p27 in Squamous Cell Carcinoma of the EsophagusPathology - Research and Practice, 2001